Pu et al. showed that PRMT4 upregulation in cisplatin-resistant NPC cells enhanced Nrf2 and GPX4 expression, thereby attenuating erastin-induced ferroptosis [32]. This evidence concerns the gene GPX4 and nasopharyngeal carcinoma.